Publications by authors named "Moses Wilks"

Spinal cord injuries (SCIs) often lead to lifelong disability. Among the various types of injuries, incomplete and discomplete injuries, where some axons remain intact, offer potential for recovery. However, demyelination of these spared axons can worsen disability.

View Article and Find Full Text PDF

Carfentanil, a highly potent synthetic opioid, paradoxically serves as a crucial positron emission tomography (PET) imaging tool in neurobiological studies of the mu-opioid receptor (MOR) system when labeled with carbon-11 ([C]CFN). However, its clinical research use is hindered by extreme potency and the limited availability of short-lived carbon-11 ( = 20.4 min).

View Article and Find Full Text PDF

Radiopharmaceutical therapy (RPT) is an emerging prostate cancer treatment that delivers radiation to specific molecules within the tumor microenvironment (TME), causing DNA damage and cell death. Given TME heterogeneity, it's crucial to explore RPT dosimetry and biological impacts at the cellular level. We integrated spatial transcriptomics (ST) with computational modeling to investigate the effects of RPT targeting prostate-specific membrane antigen (PSMA), fibroblast activation protein (FAP), and gastrin-releasing peptide receptor (GRPR) each labelled with beta-emitting lutetium-177 (Lu) and alpha-emitting actinium-225 (Ac).

View Article and Find Full Text PDF

People with human immunodeficiency virus (HIV, PWH) face an increased risk of cardiovascular disease (CVD) compared to the general population. We previously demonstrated that people with (versus without) HIV have higher macrophage-specific arterial infiltration in relation to systemic monocyte activation. We now show that select T lymphocyte subpopulations (naïve CD4 + , effector memory CD4 + , and central memory CD8 + ) are differentially associated with macrophage-specific arterial infiltration among participants with versus without HIV, with evidence of interaction by HIV status.

View Article and Find Full Text PDF

Spinal cord injuries (SCI) often lead to lifelong disability. Among the various types of injuries, incomplete and discomplete injuries, where some axons remain intact, offer potential for recovery. However, demyelination of these spared axons can worsen disability.

View Article and Find Full Text PDF

Background: 4-Aminopyridine (4AP) is a medication for the symptomatic treatment of multiple sclerosis. Several 4AP-based PET tracers have been developed for imaging demyelination. In preclinical studies, [C]3MeO4AP has shown promise due to its high brain permeability, high metabolic stability, high plasma availability, and high in vivo binding affinity.

View Article and Find Full Text PDF

Recent studies have shown that the epigenetic protein histone deacetylase 11 (HDAC11) is highly expressed in the brain and critically modulates neuroimmune functions, making it a potential therapeutic target for neurological disorders. Herein, we report the development of PB94, which is a novel HDAC11 inhibitor. PB94 exhibited potency and selectivity against HDAC11 with IC = 108 nM and >40-fold selectivity over other HDAC isoforms.

View Article and Find Full Text PDF

Purpose: 4-Aminopyridine (4AP) is a medication for the symptomatic treatment of multiple sclerosis. Several 4AP-based PET tracers have been developed for imaging demyelination. In preclinical studies, [ C]3MeO4AP has shown promise due to its high brain permeability, high metabolic stability, high plasma availability, and high binding affinity.

View Article and Find Full Text PDF
Article Synopsis
  • [F]3F4AP is a new PET radiotracer that targets potassium channels and shows potential for imaging neurological diseases, specifically demyelinated lesions, in animal studies, prompting its evaluation in humans for safety and radiation dosimetry.
  • In a study with four healthy volunteers, the radiotracer was administered and monitored through a 4-hour dynamic PET scan, revealing the tracer's highest concentrations in organs like the kidneys, liver, and brain, with rapid clearance from the body.
  • The average effective dose of radiation exposure from [F]3F4AP in humans was determined to be lower than in previous animal studies, and the safety findings showed no significant adverse effects
View Article and Find Full Text PDF

The two tandem bromodomains of BET (bromodomain and extra-terminal domain) proteins (BD1 and BD2) may play distinct and critical roles in neurological diseases. To better understand the underlying mechanisms of the BD1 bromodomain and facilitate brain permeable domain-selective inhibitor development, we describe here the development of the first BET BD1 positron emission tomography (PET) radioligand [C]1a. Compound 1a was tested to possess potent binding affinities and good selectivity (>20-fold over BD2) for BD1 bromodomains of BRD2 ( = 25 nM), BRD3 ( = 24 nM), and BRD4 ( = 19 nM).

View Article and Find Full Text PDF

Background: Persistent immune activation is thought to contribute to heightened atherosclerotic cardiovascular disease (ASCVD) risk among people with human immunodeficiency virus (PWH).

Methods: Participants (≥18 years) with or without human immunodeficiency virus (HIV) and without history of clinical ASCVD were enrolled. We hypothesized that increased macrophage-specific arterial infiltration would relate to plaque composition and systemic immune activation among PWH.

View Article and Find Full Text PDF
Article Synopsis
  • Successful imaging of atherosclerosis is important for diagnosis and treatment, with near-infrared fluorescence (NIRF) imaging being a key method used alongside hybrid imaging systems.
  • The study evaluated two fluorescent tracers aimed at macrophages (TLR4-ZW800-1C and Feraheme-Alexa Fluor 750) in a mouse model, showing that both tracers had high uptake in the atherosclerotic artery compared to a control artery.
  • The favorable renal clearance of ZW800-1C and the FDA approval of Feraheme suggest these tracers are promising candidates for further research in larger animal models and clinical applications in NIRF imaging.
View Article and Find Full Text PDF

In positron emission tomography (PET), the finite range over which positrons travel before annihilating with an electron places a fundamental physical limit on the spatial resolution of PET images. After annihilation, the photon pair detected by the PET instrumentation is emitted from a location that is different from the positron-emitting source, resulting in image blurring. Here, we report on the localization of positron range, and hence annihilation quanta, by strong nanoscale magnetization of superparamagnetic iron oxide nanoparticles (SPIONs) in PET-MRI.

View Article and Find Full Text PDF
Article Synopsis
  • Demyelination leads to slowed neuronal signals and increased disability in conditions like multiple sclerosis, making effective imaging crucial for understanding these issues.
  • Current MRI techniques are effective at identifying demyelination but struggle to provide detailed molecular insights and quantitative measures of changes in the brain.
  • The study explores the PET tracer [F]3F4AP, which shows promising results for imaging low myelin areas and for detecting previous brain injuries with greater sensitivity compared to traditional imaging methods.
View Article and Find Full Text PDF
Article Synopsis
  • This study aims to create a new type of nanoparticle for better diagnostic imaging that can be used in both PET and MR scans without the need for chelators.
  • Researchers successfully labeled a super-paramagnetic iron oxide nanoparticle with a radiotracer, achieving high radiochemical yield and purity, while confirming effective integration and contrast properties through imaging tests.
  • The findings highlight that the developed nanoparticle could enhance image quality by providing improved spatial resolution and signal-to-noise ratio during concurrent PET-MR imaging, demonstrating its potential as a valuable diagnostic tool.
View Article and Find Full Text PDF

Purpose: Using our chelate-free, heat-induced radiolabeling (HIR) method, we show that a wide range of metals, including those with radioactive isotopologues used for diagnostic imaging and radionuclide therapy, bind to the Feraheme (FH) nanoparticle (NP), a drug approved for the treatment of iron anemia.

Material And Methods: FH NPs were heated (120°C) with nonradioactive metals, the resulting metal-FH NPs were characterized by inductively coupled plasma mass spectrometry (ICP-MS), dynamic light scattering (DLS), and r and r relaxivities obtained by nuclear magnetic relaxation spectrometry (NMRS). In addition, the HIR method was performed with [Y]Y, [Lu]Lu, and [Cu]Cu, the latter with an HIR technique optimized for this isotope.

View Article and Find Full Text PDF

Immunotherapy, specifically the introduction of immune checkpoint inhibitors, has transformed the treatment of cancer, enabling long-term tumour control even in individuals with advanced-stage disease. Unfortunately, only a small subset of patients show a response to currently available immunotherapies. Despite a growing consensus that combining immune checkpoint inhibitors with radiotherapy can increase response rates, this approach might be limited by the development of persistent radiation-induced immunosuppression.

View Article and Find Full Text PDF

It is well understood that fatty acids can be synthesized, imported, and modified to meet requisite demands in cells. However, following the movement of fatty acids through the multiplicity of these metabolic steps has remained difficult. To better address this problem, we developed Fatty Acid Source Analysis (FASA), a model that defines the contribution of synthesis, import, and elongation pathways to fatty acid homeostasis in saturated, monounsaturated, and polyunsaturated fatty acid pools.

View Article and Find Full Text PDF

Feraheme (FH) nanoparticles (NPs) have been used extensively for treatment of iron anemia (due to their slow release of ionic iron in acidic environments). In addition, injected FH NPs are internalized by monocytes and function as MRI biomarkers for the pathological accumulation of monocytes in disease. We have recently expanded these applications by radiolabeling FH NPs for positron emission tomography (PET) or single-photon emission computed tomography (SPECT) imaging using a heat-induced radiolabeling (HIR) strategy.

View Article and Find Full Text PDF

Chronic wounds affect 12-15% of patients with diabetes and are associated with a drastic decrease in their quality of life. Here, we demonstrate that purified mature naive B220 /CD19 /IgM /IgD B cells improve healing of acute and diabetic murine wounds after a single topical application. B cell treatment significantly accelerated acute wound closure by 2-3 days in wild-type mice and 5-6 days in obese diabetic mice.

View Article and Find Full Text PDF

A key advantage of nanomaterials for biomedical applications is their ability to feature multiple small reporter groups (multimodality), or combinations of reporter groups and therapeutic agents (multifunctionality), while being targeted to cell surface receptors. Here a facile combination of techniques for the syntheses of multimodal, targeted nanoparticles (NPs) is presented, whereby heat-induced-radiolabeling (HIR) labels NPs with radiometals and so-called click chemistry is used to attach bioactive groups to the NP surface. Click-reactive alkyne or azide groups were first attached to the nonradioactive clinical Feraheme (FH) NPs.

View Article and Find Full Text PDF

Background: The ability to noninvasively assess arterial CD206+ macrophages may lead to improved understanding of human immunodeficiency virus (HIV)-associated cardiovascular disease.

Methods: We trialed a novel macrophage-specific arterial imaging technique.

Results: We demonstrated colocalization between technetium Tc 99m tilmanocept (99mTc-tilmanocept) and CD206+ macrophages ex vivo.

View Article and Find Full Text PDF

Cellular lipid requirements are achieved through a combination of biosynthesis and import programs. Using isotope tracer analysis, we show that type I interferon (IFN) signaling shifts the balance of these programs by decreasing synthesis and increasing import of cholesterol and long chain fatty acids. Genetically enforcing this metabolic shift in macrophages is sufficient to render mice resistant to viral challenge, demonstrating the importance of reprogramming the balance of these two metabolic pathways in vivo.

View Article and Find Full Text PDF

Heat-induced radiolabeling (HIR) yielded (89) Zr-Feraheme (FH) nanoparticles (NPs) that were used to determine NP pharmacokinetics (PK) by positron emission tomography (PET). Standard uptake values indicated a fast hepatic uptake that corresponded to blood clearance, and a second, slow uptake process by lymph nodes and spleen. By cytometry, NPs were internalized by circulating monocytes and monocytes in vitro.

View Article and Find Full Text PDF

PICALM (Phosphatidyl Inositol Clathrin Assembly Lymphoid Myeloid protein) is a ubiquitously expressed protein that plays a role in clathrin-mediated endocytosis. PICALM also affects the internalization and trafficking of SNAREs and modulates macroautophagy. Chromosomal translocations that result in the fusion of PICALM to heterologous proteins cause leukemias, and genome-wide association studies have linked PICALM Single Nucleotide Polymorphisms (SNPs) to Alzheimer's disease.

View Article and Find Full Text PDF